Cott (TSE:PRM) Upgraded to “Strong-Buy” at BMO Capital Markets

BMO Capital Markets upgraded shares of Cott (TSE:PRM) to a strong-buy rating in a report released on Monday,Zacks.com reports.

PRM has been the subject of several other reports. Raymond James lowered shares of Cott from a “moderate buy” rating to a “hold” rating in a report on Wednesday, October 2nd. William Blair upgraded Cott to a “strong-buy” rating in a research note on Thursday, October 24th.

Cott Price Performance

Cott stock opened at C$13.30 on Monday. Cott has a 52 week low of C$12.95 and a 52 week high of C$14.97. The firm’s 50 day simple moving average is C$13.26.

Cott Dividend Announcement

The firm also recently announced a None dividend, which was paid on Thursday, November 21st. Shareholders of record on Tuesday, November 5th were issued a dividend of $1.109 per share. The ex-dividend date was Tuesday, November 5th.

Cott Company Profile

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.